People channel feed – Endpoints News

People channel feed

Good year, bad year? Two biotech CEOs hit pay dirt in 2018 as compensation packages swell

7 years ago

Novartis CEO Narasimhan raids GlaxoSmithKline offices for his new Sandoz chief

7 years ago

‘Chief bluebird’ Nick Leschly nails a rich $24M compensation bounty as biotech packages soar

7 years ago

What’s it take to recruit a top drug development exec out of Gilead? Stock options help, a lot

7 years ago

Seattle Genetics CEO Clay Siegall's comp package soars to $18.1M, rivaling Big Pharma chiefs

7 years ago

Jeff Aronin's startup incubator scoops ex-Alkermes exec Jim Robinson for new president/COO role

7 years ago

France's Sanofi contributes €10M to the restoration of Notre Dame

7 years ago

'Patients are not a company's resource': FDA cancer czar Richard Pazdur has a bone to pick with the top R&D execs in cancer

7 years ago

Ned Sharpless is not playing with the FDA’s gold standard — any more than Scott Gottlieb did

7 years ago

Revenue plunges, stock takes a drubbing, but Teva CEO Kåre Schultz still grabs $32.5M in chart-topping compensation

7 years ago

Forget biosimilars. Peter Bach and Mark Trusheim believe price controls are the better way to rein in biologics prices

7 years ago

With $150M and a new NASH discovery deal with Gilead, AI star Daphne Koller has set out to change the drug R&D world

7 years ago

Influential proxy firms kick back at activists’ demands for Brent Saunders to give up his chairman’s title at Allergan

7 years ago

Road warrior: Hal Barron's global R&D crusade at GSK comes with a hefty $800,000-plus travel budget

7 years ago

Two more Big Pharma CEOs enjoyed hefty raises in 2018, leaving the industry’s only major league female chief in firm control of last place

7 years ago

Peter Hecht recruits Bayer/Shire vet Andreas Busch for a top R&D post at his $175M biotech spinout

7 years ago

Tapped as Kymab CEO, Simon Sturge jumps back into biotech pond as Dave Chiswell steps aside

7 years ago

Outside review confirms top Memorial Sloan Kettering executives flouted conflicts-of-interest policies — report

7 years ago

Already missing FDA's vocal commish? Scott Gottlieb will keep chiming in on drug pricing in new role

7 years ago

Biotech billionaire faces accusations of fraud for $1.3B 'catch-and-kill' cancer drug deal

7 years ago

AbbVie shareholder joins the growing ranks of critics, calling for an independent chairman

7 years ago

Sure Hervé Hoppenot took a big cut in compensation after a pipeline disaster. But he still outscored the only woman on the list

7 years ago

After a 33-year odyssey, Jeffrey Bluestone grabs a ringside seat to watch his drug teplizumab go back into the clinic

7 years ago

Jim Mellon's Juvenescence takes a chance on tiny upstart run by former Pfizer exec

7 years ago

First page Previous page 79 80 818283 84 85 Next page Last page